Nadia Wohlwend

481 total citations
8 papers, 118 citations indexed

About

Nadia Wohlwend is a scholar working on Infectious Diseases, Animal Science and Zoology and Clinical Biochemistry. According to data from OpenAlex, Nadia Wohlwend has authored 8 papers receiving a total of 118 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 2 papers in Animal Science and Zoology and 2 papers in Clinical Biochemistry. Recurrent topics in Nadia Wohlwend's work include SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (3 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Nadia Wohlwend is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (3 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Nadia Wohlwend collaborates with scholars based in Switzerland, Liechtenstein and Germany. Nadia Wohlwend's co-authors include Thierry Francey, Vincent Perreten, Andrea Endimiani, Lorenz Risch, Martin Risch, Thomas Bodmer, Daniel E Jonas, Katleen Vranckx, Adrian Egli and Florian P. Maurer and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Nadia Wohlwend

7 papers receiving 114 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia Wohlwend Switzerland 5 48 44 39 27 26 8 118
Ornuma Sangwichian Thailand 9 26 0.5× 63 1.4× 33 0.8× 24 0.9× 27 1.0× 10 170
Ariane Dinkelacker Netherlands 5 31 0.6× 71 1.6× 61 1.6× 22 0.8× 21 0.8× 5 191
Carlos Ruiz de Alegría Puig Spain 10 63 1.3× 33 0.8× 21 0.5× 18 0.7× 64 2.5× 29 201
Joaquim Viñes Spain 7 49 1.0× 33 0.8× 32 0.8× 18 0.7× 12 0.5× 13 143
Barry N Kreiswirth United States 5 26 0.5× 48 1.1× 29 0.7× 14 0.5× 17 0.7× 13 92
Fahad Khokhar United Kingdom 6 24 0.5× 33 0.8× 17 0.4× 17 0.6× 14 0.5× 12 82
Priscila Lamb Wink Brazil 9 77 1.6× 108 2.5× 55 1.4× 26 1.0× 36 1.4× 36 244
Hiroaki Baba Japan 7 45 0.9× 29 0.7× 14 0.4× 12 0.4× 15 0.6× 27 133
Emma G. Mills United States 8 26 0.5× 107 2.4× 34 0.9× 17 0.6× 26 1.0× 16 193
Denise van Hout Netherlands 8 29 0.6× 73 1.7× 11 0.3× 11 0.4× 23 0.9× 9 147

Countries citing papers authored by Nadia Wohlwend

Since Specialization
Citations

This map shows the geographic impact of Nadia Wohlwend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Wohlwend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Wohlwend more than expected).

Fields of papers citing papers by Nadia Wohlwend

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Wohlwend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Wohlwend. The network helps show where Nadia Wohlwend may publish in the future.

Co-authorship network of co-authors of Nadia Wohlwend

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Wohlwend. A scholar is included among the top collaborators of Nadia Wohlwend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Wohlwend. Nadia Wohlwend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Egli, Konrad, Faina Wehrli, Martin Risch, et al.. (2025). Evaluation of the Allplex NG & DR assay for molecular prediction of ciprofloxacin and azithromycin resistance in Neisseria gonorrhoeae. European Journal of Clinical Microbiology & Infectious Diseases. 44(4). 923–932.
2.
3.
Wehrli, Faina, Martin Risch, Lorenz Risch, et al.. (2023). SARS-CoV-2 Nucleocapsid Protein Mutations Found in Switzerland Disrupt N-Gene Amplification in Commonly Used Multiplex RT-PCR Assay. Pathogens. 12(12). 1383–1383. 2 indexed citations
4.
Weber, Myriam, Lorenz Risch, Nadia Wohlwend, et al.. (2020). Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein – an observational study. Swiss Medical Weekly. 150(4142). w20361–w20361. 6 indexed citations
5.
Risch, Lorenz, Myriam Weber, Nadia Wohlwend, et al.. (2020). Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study. Clinical Chemistry and Laboratory Medicine (CCLM). 59(2). e49–e51. 13 indexed citations
6.
7.
8.
Wohlwend, Nadia, Andrea Endimiani, Thierry Francey, & Vincent Perreten. (2015). Third-Generation-Cephalosporin-Resistant Klebsiella pneumoniae Isolates from Humans and Companion Animals in Switzerland: Spread of a DHA-Producing Sequence Type 11 Clone in a Veterinary Setting. Antimicrobial Agents and Chemotherapy. 59(5). 2949–2955. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ornuma Sangwichian Breakdown of academic impact, for papers by Ariane Dinkelacker Breakdown of academic impact, for papers by Carlos Ruiz de Alegría Puig Breakdown of academic impact, for papers by Joaquim Viñes Breakdown of academic impact, for papers by Barry N Kreiswirth Breakdown of academic impact, for papers by Fahad Khokhar Breakdown of academic impact, for papers by Priscila Lamb Wink Breakdown of academic impact, for papers by Hiroaki Baba Breakdown of academic impact, for papers by Emma G. Mills Breakdown of academic impact, for papers by Denise van Hout
Rankless by CCL
2026